Geode Capital Management
RMTI icon

Geode Capital Management’s Rockwell Medical RMTI Stock Holding History

Geode Capital Management’s Portfolio RMTI Stock Details RMTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$383K Buy
42,918
+6,436
+18% +$64.1K ﹤0.01% 3685
2025
Q4 		$304K Buy
36,482
+4,167
+13% +$42K ﹤0.01% 3768
2025
Q3 		$388K Buy
32,315
+248
+0.8% +$3.03K ﹤0.01% 3713
2025
Q2 		$272K Sell
32,067
-387
-1% -$3.94K ﹤0.01% 3771
2025
Q1 		$367K Buy
32,454
+412
+1% +$7.48K ﹤0.01% 3655
2024
Q4 		$654K Buy
32,042
+1,313
+4% +$38.3K ﹤0.01% 3520
2024
Q3 		$1.22M Buy
30,729
+194
+0.6% +$5.22K ﹤0.01% 3290
2024
Q2 		$538K Buy
30,535
+1,659
+6% +$28.1K ﹤0.01% 3545
2024
Q1 		$479K Buy
28,876
+484
+2% +$7.04K ﹤0.01% 3634
2023
Q4 		$537K Buy
28,392
+4,091
+17% +$76.8K ﹤0.01% 3589
2023
Q3 		$506K Buy
24,301
+13,704
+129% +$416K ﹤0.01% 3597
2023
Q2 		$579K Buy
10,597
+4,446
+72% +$137K ﹤0.01% 3585
2023
Q1 		$111K Hold
6,151
– – ﹤0.01% 4301
2022
Q4 		$62K Sell
6,151
-16
-0.3% -$171 ﹤0.01% 4535
2022
Q3 		$81K Hold
6,167
– – ﹤0.01% 4645
2022
Q2 		$79K Sell
6,167
-1
-0% -$26 ﹤0.01% 4662
2022
Q1 		$319K Hold
6,168
– – ﹤0.01% 4155
2021
Q4 		$278K Sell
6,168
-298
-5% -$16K ﹤0.01% 4331
2021
Q3 		$423K Sell
6,466
-1
-0% -$76 ﹤0.01% 4109
2021
Q2 		$647K Sell
6,467
-4,847
-43% -$500K ﹤0.01% 3815
2021
Q1 		$1.44M Buy
11,314
+3,232
+40% +$478K ﹤0.01% 3413
2020
Q4 		$897K Sell
8,082
-366
-4% -$41K ﹤0.01% 3396
2020
Q3 		$994K Buy
8,448
+292
+4% +$50.5K ﹤0.01% 3211
2020
Q2 		$1.75M Buy
8,156
+65
+0.8% +$15.4K ﹤0.01% 2915
2020
Q1 		$1.82M Buy
8,091
+809
+11% +$231K ﹤0.01% 2716
2019
Q4 		$1.95M Buy
7,282
+594
+9% +$149K ﹤0.01% 3017
2019
Q3 		$2.03M Buy
6,688
+321
+5% +$98.7K ﹤0.01% 2935
2019
Q2 		$2.11M Buy
6,367
+662
+12% +$336K ﹤0.01% 2913
2019
Q1 		$3.57M Buy
5,705
+798
+16% +$364K ﹤0.01% 2515
2018
Q4 		$1.22M Buy
4,907
+521
+12% +$207K ﹤0.01% 3021
2018
Q3 		$2.04M Buy
4,386
+156
+4% +$75.6K ﹤0.01% 2868
2018
Q2 		$2.29M Buy
4,230
+424
+11% +$254K ﹤0.01% 2773
2018
Q1 		$2.18M Buy
3,806
+46
+1% +$29K ﹤0.01% 2709
2017
Q4 		$2.41M Buy
3,760
+50
+1% +$35.2K ﹤0.01% 2642
2017
Q3 		$3.49M Buy
3,710
+69
+2% +$52.8K ﹤0.01% 2416
2017
Q2 		$3.18M Buy
3,641
+262
+8% +$215K ﹤0.01% 2454
2017
Q1 		$2.33M Buy
3,379
+300
+10% +$198K ﹤0.01% 2580
2016
Q4 		$2.22M Buy
3,079
+75
+2% +$51.8K ﹤0.01% 2572
2016
Q3 		$2.21M Buy
3,004
+61
+2% +$49.4K ﹤0.01% 2501
2016
Q2 		$2.45M Buy
2,943
+148
+5% +$138K ﹤0.01% 2355
2016
Q1 		$2.31K Buy
2,795
+23
+0.8% +$18.1K ﹤0.01% 2361
2015
Q4 		$3.12M Buy
2,772
+48
+2% +$55.8K ﹤0.01% 2189
2015
Q3 		$2.31M Buy
2,724
+141
+5% +$204K ﹤0.01% 2353
2015
Q2 		$4.58M Buy
2,583
+135
+6% +$172K ﹤0.01% 1949
2015
Q1 		$2.94M Buy
2,448
+139
+6% +$163K ﹤0.01% 2188
2014
Q4 		$2.61M Buy
2,309
+485
+27% +$497K ﹤0.01% 2257
2014
Q3 		$1.83M Buy
1,824
+103
+6% +$116K ﹤0.01% 2409
2014
Q2 		$2.27M Buy
1,721
+24
+1% +$28.9K ﹤0.01% 2293
2014
Q1 		$2.36M Buy
1,697
+51
+3% +$66.3K ﹤0.01% 2236
2013
Q4 		$1.89M Buy
1,646
+210
+15% +$290K ﹤0.01% 2324
2013
Q3 		$1.8M Buy
1,436
+119
+9% +$80.8K ﹤0.01% 2236
2013
Q2 		$523K Buy
+1,317
New +$558K ﹤0.01% 2847

Other funds holding RMTI

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WANY
Wealthspire Advisors (New York) New York $12.7B AUM 17.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Geode Capital Management's RMTI Position: Q1 2026 in Review

Geode Capital Management increased its Rockwell Medical (RMTI) stake by 18% in Q1 2026, buying an estimated $64.1K and bringing the position to 42,918 shares worth $383K. The position accounts for ﹤0.01% of the portfolio, ranked #3685.

Geode Capital Management first reported a position in RMTI in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.58M in Q2 2015. 42 funds tracked by Wall St. Rank hold RMTI as of Q1 2026.

  • Geode Capital Management held 42,918 shares of Rockwell Medical worth $383K as of Q1 2026.
  • Geode Capital Management bought 6,436 Rockwell Medical shares in Q1 2026, an estimated $64.1K.
  • Rockwell Medical made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #3685 holding.
  • Geode Capital Management first reported a position in Rockwell Medical in Q2 2013 and has held it in 52 quarters since.
  • Geode Capital Management's Rockwell Medical position peaked at $4.58M in Q2 2015.
  • 42 funds tracked by Wall St. Rank held Rockwell Medical as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.